We are pleased to announce that the 1st Annual European Healthcare Impact Summit (#Sachs_EHIS) will take place on the 6th of October 2026 at the Mövenpick Hotel Basel. The event will be part of the Sachs Autumn Life Sciences Week (#SALSW), which will also incorporate the 26th Annual Biotech in Europe Forum (#Sachs_BEF).
The EHIS will replace the 13th Annual HealthTech Investment Forum (#Sachs_HTIF), previously hosted in Basel, and the 8th Annual HealthTech Innovation Days (HTID), previously hosted in Paris. It will continue HTID’s tradition of hosting a high-profile October summit, advancing discussions across the European healthcare ecosystem, and bringing innovative solutions to patients. The programme will highlight European world-leading innovation across multiple medical fields, including orphan diseases.
The physical programme will consist of panels and keynotes/workshops, which will be available on-demand by the 15th of October. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases, as well as a networking reception. Recordings of the presentations will be uploaded by the 13th of October. During the online week, virtual meetings will be available through the online meeting system.
We anticipate around 300 delegates attending in-person & virtually, with up to 20 company presentations by established and emerging companies offering innovative solutions, seeking investment, and partnering opportunities. This will include a limited number of live presentations taking place in a dedicated parallel presentation track, alongside virtual company showcases, which will be available on demand. Recorded sessions will also be added on demand on the Event Portal during the virtual week.
The SALSW brings together a global audience of senior pharma, biotech, HealthTech, MedTech and digital health executives, alongside bankers, consultants, financial and corporate investors, along with a select number of service providers. The EHIS will focus on the broader healthcare ecosystem, bringing together KOLs, leading healthcare organisations, hospitals, scientists, and life sciences and HealthTech executives. Its programme will highlight innovation across medtech/devices, diagnostics, drug discovery, and digital health.
The In-Person meetings will take place during the physical event on the 6th of October, while virtual meetings will be held from the 13th - 15th of October. For virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function, and we will have a dedicated room for in-person meetings. We expect over 2000 meetings to be completed during SALSW. The conference will be held in the Central European Summer Time (CEST) zone.
The programme will consist of:
- Keynote Speech: "Financing Europe’s Life Sciences Future: The EIB Perspective on Competitiveness, Innovation & Scale"
- New Initiatives Panel: Strengthening Europe’s Biotech & Life Sciences Investment Outlook
- Fireside Chat with Big Pharma
- Introduction Speech
- Oncology True Innovation Panel: Building on World-Class Science
- Pharma-Biotech Partnering in Emerging Technology Platforms Panel
- Keynote Speech: Building a European Unicorn
- Traumatic Brain Injury Panel
- Keynote Speech: “Where Spinal Surgery Meets Pain Management: The Huge Unmet Need“
- Investment Strategies in Next-Generation MedTech & Devices Panel
- Chair’s Concluding Remarks
Networking Reception – 6th of October (18:00 - 19:00 CEST)
In-Person Meetings – 6th of October (09:20 - 18:00 CEST)
Virtual Meetings via Online Meeting System – 13th – 15th of October
Confirmed Keynote Speakers Include:
- Camille Srour, CEO, CS-Medica
- Cristina Niculescu, Lead Life Science Specialist, European Investment Bank
Confirmed Chairs & Speakers Include:
- Barbara Lueckel, Global Head of Research Technologies Partnering, F. Hoffmann-La Roche AG
- Camille Srour, CEO, CS-Medica
- Cem Baydar, Senior Advisor and Board Member, Afendis Capital Management
- Chris Church, Associate Director, CVRM Search & Evaluation, AstraZeneca
- Cindy Daniel, Head of Unit, European Investment Fund
- Cristina Niculescu, Lead Life Science Specialist, European Investment Bank
- Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA
- Eyal Lifschitz, Co-Founder & General Managing Partner, Peregrine Ventures
- Jorge Cancela, Digital Health Leader, F. Hoffmann-La Roche AG
- Marc Dechamps, CEO, Bioxodes SA
- Michalis Papadakis, Co-Founder & CEO, Brainomix Limited
- Miro Venturi, Operating Partner & Executive, ARCHIMED
- Philippe Monteyne, Chairman of Boards & Senior Advisor, AltamarCAM Partners
- Rainer Strohmenger, Managing Partner, Wellington Partners
- Ricardo Pacheco, Strategic Partnering, BD&L Director, Insilico Medicine
- Sabin Minguez, Senior Director, R&D Business Development, GSK
- Sandra von Meier, Head of Business Development Life Science, Terra Quantum AG
- Sarah Holland, President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
- Stephanie Léouzon, Managing Director, Vice Chair of European Healthcare Investment Banking, Stifel
- Uriah Bekenstein, CEO, Nucleotch
- More TBA...
